Collaborative Programs to Refine Human Predictive Models of Inflammation in Lung and Gastrointestinal Diseases
Results published in Nature Methods with pharmaceutical collaborators use Organs-on-Chips to model diseases of the human Lung Small Airway-on-Chip
Data demonstrate differentiation of patient iPS cells into endothelial cells and neurons, using Organs-on-Chips to model the human brain’s microenvironment – providing a system to improve R&D for drug development for neurodegenerative diseases.
The studies will evaluate potential safety challenges of LRRK2 kinase inhibitors to drive improvements within this promising therapeutic class of medicines that target the underlying biology of Parkinson’s disease.
Organs-on-Chips are recognized for the potential to reduce animal testing, revolutionize the development of new drugs, and open a new era of personalized health
Collaboration Yields First Demonstration of Thrombosis on-Chip, Improving Drug Candidate Design, Selection
Human Organs-on-Chips will now compete with other category winners, such as Google’s Self Driving Car, for overall Design of the Year award. Annual design awards presented by London’s Design Museum
Technology Nominated for Design of Year Award, To Be Featured in Exhibitions at MoMA in New York and Design Museum in London